Search Results - "Bright, Jeremy R."

“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis by Giovannoni, Gavin, Tomic, Davorka, Bright, Jeremy R, Havrdová, Eva

“…Using combined endpoints to define no evident disease activity (NEDA) is becoming increasingly common when setting targets for treatment outcomes in multiple…”
Get full text

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis by Radue, Ernst-Wilhelm, Barkhof, Frederik, Kappos, Ludwig, Sprenger, Till, Häring, Dieter A, de Vera, Ana, von Rosenstiel, Philipp, Bright, Jeremy R, Francis, Gordon, Cohen, Jeffrey A

“…OBJECTIVE:We investigated the determinants and clinical correlations of MRI-detected brain volume loss (BVL) among patients with relapsing-remitting multiple…”
Get full text

Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Patient Education by Kantor, Daniel, Bright, Jeremy R., Burtchell, Jeri

“…A diagnosis of multiple sclerosis (MS) is life-altering. Because the course of MS is heterogeneous, patients may face uncertainty in terms of long-term…”
Get full text

Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory Medicine by Kantor, Daniel, Bright, Jeremy R., Burtchell, Jeri

“…When faced with a diagnosis of multiple sclerosis (MS), patients often turn to the Internet and social media to find support groups, read about the experiences…”
Get full text

Scoring system to facilitate diagnosis of Gaucher disease by Mehta, Atul, Rivero‐Arias, Oliver, Abdelwahab, Magy, Campbell, Samantha, McMillan, Annabel, Rolfe, Mark J., Bright, Jeremy R., Kuter, David J.

“…Background Gaucher disease (GD) manifests heterogeneously and other conditions are often misdiagnosed in its place, leading to diagnostic delays. The Gaucher…”
Get full text

Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain by Pickford, Andrew R, Potts, Jennifer R, Bright, Jeremy R, Phan, Isabelle, Campbell, Iain D

“…Background: Fibronectin is an extracellular matrix glycoprotein involved in cell adhesion and migration events in a range of important physiological processes…”
Get full text

Biological activity, membrane‐targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli by White, Jennifer, Lukacik, Petra, Esser, Dirk, Steward, Michael, Giddings, Naomi, Bright, Jeremy R., Fritchley, Sarah J., Morgan, B. Paul, Lea, Susan M., Smith, Geoffrey P., Smith, Richard A.G.

“…Decay‐accelerating factor (DAF, CD55) is a glycophosphatidyl inositol‐anchored glycoprotein that regulates the activity of C3 and C5 convertases. In addition…”
Get full text

Solution Structure of the N-Terminal F1 Module Pair from Human Fibronectin by Potts, Jennifer R, Bright, Jeremy R, Bolton, David, Pickford, Andrew R, Campbell, Iain D

“…Multiple sites within the N-terminal domain (1-5F1) of fibronectin have been implicated previously in fibronectin matrix assembly, heparin binding, and binding…”
Get full text

Identification of Residues Involved in the Interaction of Staphylococcus aureus Fibronectin-Binding Protein with the 4F15F1 Module Pair of Human Fibronectin Using Heteronuclear NMR Spectroscopy by Penkett, Christopher J, Dobson, Christopher M, Smith, Lorna J, Bright, Jeremy R, Pickford, Andrew R, Campbell, Iain D, Potts, Jennifer R

“…Many pathogenic Gram-positive bacteria express cell surface proteins that bind to components of the extracellular matrix. This paper describes studies of the…”
Get full text

Cloning, sequencing and expression of the gene encoding glucose dehydrogenase from the thermophilic archaeon Thermoplasma acidophilum by BRIGHT, Jeremy R., BYROM, David, DANSON, Michael J., HOUGH, David W., TOWNER, Paul

“…The gene encoding glucose dehydrogenase has been identified by Southern analysis of doubly restricted genomic Thermoplasma acidophilum DNA, using two redundant…”
Get full text

Third meeting on Novel Adjuvants Currently in or Close to Clinical Testing World Health Organization--Organisation Mondiale de la Santé, Fondation Mérieux, Annecy, France, 7-9 January 2002 by Engers, Howard, Kieny, Marie Paule, Malhotra, Pawan, Pink, J Richard

Get full text

Identification of Residues Involved in the Interaction of Staphylococcus aureus Fibronectin-Binding Protein with the 4 F1 5 F1 Module Pair of Human Fibronectin Using Heteronuclear NMR Spectroscopy by Penkett, Christopher J., Dobson, Christopher M., Smith, Lorna J., Bright, Jeremy R., Pickford, Andrew R., Campbell, Iain D., Potts, Jennifer R.

Get full text

Cloning, sequencing and expression of glucose dehydrogenase from thermoplasma acidophilum by Bright, Jeremy R

“…The N-terminal amino acid sequence of the dual-nicotinamide-cofactor specific enzyme, glucose dehydrogenase (EC 1.1.1.47), from the ther-moacidophilic…”
Get full text

Cloning, sequencing and expression of glucose dehydrogenase from Thermoplasma acidophilum by Bright, Jeremy R

Get full text

Crystallization and preliminary crystallographic study of glucose dehydrogenase from the archaebacterium Thermoplasma acidophilum by Bright, J R, Mackness, R, Danson, M J, Hough, D W, Taylor, G L, Towner, P, Byrom, D

“…Single crystals of glucose dehydrogenase from the archaebacterium Thermoplasma acidophilum were obtained using the hanging-drop vapour diffusion method and…”
Get more information